Related Experiment Videos

Enzyme inhibitors in medicine

C S Walpole¹, R Wrigglesworth

¹Sandoz Institute for Medical Research, London.

Natural Product Reports

|August 1, 1989

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

CoMFA and CoMSIA 3D-quantitative structure-activity relationship model on benzodiazepine derivatives, inhibitors of phosphodiesterase IV.

Journal of computer-aided molecular design·2002

Design of non-peptide CCK2 and NK1 peptidomimetics using 1-(2-nitrophenyl)thiosemicarbazide as a novel common scaffold.

Bioorganic & medicinal chemistry letters·2001

Synthesis, structure-activity relationships, and pharmacological profile of 9-amino-4-oxo-1-phenyl-3,4,6,7-tetrahydro[1,4]diazepino[6, 7,1-hi]indoles: discovery of potent, selective phosphodiesterase type 4 inhibitors.

Journal of medicinal chemistry·2000

Bradyzide, a potent non-peptide B(2) bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia.

British journal of pharmacology·2000

Selective neurokinin-1 receptor antagonists are anti-hyperalgesic in a model of neuropathic pain in the guinea-pig.

Neuroscience·1998

Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist.

British journal of pharmacology·1998

See all related articles